ArticleAdvanced biomedical research2026
Sustained Lung Inflation in Preterm Infants with Signs of Respiratory Distress: A Randomized Controlled Trial.
Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The role of sustained lung inflation (SI) in neonatal resuscitation at birth as a substitute for, or an adjuvant to positive pressure ventilation (PPV) has been previously examined. This study was conducted to examine the effect of applying SI in preterm infants, who did not need PPV at birth but showed signs of respiratory distress within the first minutes of life, on their mortality and some common morbidities. Materials and Methods: In this double-blind randomized clinical trial, seventy-four preterm infants with gestational age 28-33 6/7 weeks and birth weight more than 1000 g in whom signs of respiratory distress appeared within five to ten minutes after birth were randomly assigned to receive nCPAP alone (nCPAP-only group) or a 10-second sustained inflation with 20 cmH Results: The need for surfactant administration was significantly less ( Conclusions: Applying SI within the first minutes after birth in preterm infants with early signs of respiratory distress can reduce the need for exogenous surfactant and the length of hospital stay. Further studies on the role of this modality in the management of RDS in neonates, especially its effect on long-term cardiopulmonary and neurodevelopment outcomes, are recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.